Amylyx Pharmaceuticals Announces Positive Long-Term Results From Phase 2 Helios Clinical Trial Of Amx0035 In People With Wolfram Syndrome

Published: 2025-05-12 07:30:42 ET AMLX

Published on 05/12/2025 at 07:30